BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robertson CS, Chung SC, Woods SD, Griffin SM, Raimes SA, Lau JT, Li AK. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-82. [PMID: 8053740 DOI: 10.1097/00000658-199408000-00009] [Cited by in Crossref: 248] [Cited by in F6Publishing: 210] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Songun I, van de Velde CJ. Results of completed clinical trials for gastric cancer. Eur J Surg Oncol 1995;21:588-90. [PMID: 8631398 DOI: 10.1016/s0748-7983(95)94918-6] [Reference Citation Analysis]
2 Choi YY, An JY, Katai H, Seto Y, Fukagawa T, Okumura Y, Kim DW, Kim HI, Cheong JH, Hyung WJ, Noh SH. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. PLoS One 2016;11:e0149555. [PMID: 26967161 DOI: 10.1371/journal.pone.0149555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
3 Ilhan E, Ureyen O. A Comparison of Subtotal Gastrectomy and Total Gastrectomy for Distal Gastric Cancer. Indian J Surg 2019;81:70-6. [DOI: 10.1007/s12262-018-1834-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, Abrams RA, Laheru D, Hruban RH, Yeo CJ. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005;9:1191-1204; discussion 1204-1206. [PMID: 16332474 DOI: 10.1016/j.gassur.2005.08.034] [Cited by in Crossref: 164] [Cited by in F6Publishing: 136] [Article Influence: 10.3] [Reference Citation Analysis]
5 Weber SM, Karpeh MS. Randomized Clinical Trials in Gastric Cancer. Surgical Oncology Clinics of North America 2002;11:111-31. [DOI: 10.1016/s1055-3207(03)00077-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 407] [Article Influence: 48.8] [Reference Citation Analysis]
7 Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309-315. [PMID: 16574546 DOI: 10.1016/s1470-2045(06)70623-4] [Cited by in Crossref: 424] [Cited by in F6Publishing: 191] [Article Influence: 26.5] [Reference Citation Analysis]
8 Douglass HO, Hundahl SA, Macdonald JS, Khatri VP. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate. Surg Oncol Clin N Am. 2007;16:133-155. [PMID: 17336241 DOI: 10.1016/j.soc.2006.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
9 Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S. Risk factors for complications following resection of large gastric cancer. Br J Surg 2001;88:873-7. [PMID: 11412261 DOI: 10.1046/j.0007-1323.2001.01782.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
10 Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021;10:2557. [PMID: 34207898 DOI: 10.3390/jcm10122557] [Reference Citation Analysis]
11 Barreto SG, Sirohi B. Why should we perform a D2 lymphadenectomy in gastric cancer? Future Oncol 2017;13:2009-12. [PMID: 28984466 DOI: 10.2217/fon-2017-0282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Yang SH, Zhang YC, Yang KH, Li YP, He XD, Tian JH, Lv TH, Hui YH, Sharma N. An evidence-based medicine review of lymphadenectomy extent for gastric cancer. Am J Surg. 2009;197:246-251. [PMID: 18722583 DOI: 10.1016/j.amjsurg.2008.05.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
13 Di Leo A, Marrelli D, Roviello F, Bernini M, Minicozzi A, Giacopuzzi S, Pedrazzani C, Baiocchi LG, de Manzoni G. Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg. 2007;11:1146-1153. [PMID: 17576611 DOI: 10.1007/s11605-006-0062-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
14 Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y. Total vs subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials. Onco Targets Ther. 2016;9:6795-6800. [PMID: 27853375 DOI: 10.2147/ott.s110828] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Hu Y, Vos EL, Baser RE, Schattner MA, Nishimura M, Coit DG, Strong VE. Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer. Ann Surg Oncol 2021;28:48-56. [PMID: 33125569 DOI: 10.1245/s10434-020-09274-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434. [PMID: 17435550 DOI: 10.1097/01.sla.0000245469.35088.42] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
17 Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107:807-814. [PMID: 23512524 DOI: 10.1002/jso.23325] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
18 Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyama T, Tomita F, Saito H, Kita I, Takashima S. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today. 1999;29:695-700. [PMID: 10483741 DOI: 10.1007/bf02482311] [Cited by in Crossref: 57] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
19 Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM. Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer. J Surg Res 2021;266:27-34. [PMID: 33975027 DOI: 10.1016/j.jss.2021.04.005] [Reference Citation Analysis]
20 Tsai MS, Wang YC, Kao YH, Jeng LB, Kao CH. Preexisting Diabetes and Risks of Morbidity and Mortality After Gastrectomy for Gastric Cancer: A Nationwide Database Study. Medicine (Baltimore) 2015;94:e1467. [PMID: 26376386 DOI: 10.1097/MD.0000000000001467] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery. 1998;123:127-130. [PMID: 9481396 DOI: 10.1016/s0039-6060(98)70248-x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
22 Goldfarb M, Brower S, Schwaitzberg SD. Minimally invasive surgery and cancer: controversies part 1. Surg Endosc. 2010;24:304-334. [PMID: 19572178 DOI: 10.1007/s00464-009-0583-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
23 Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink H, van de Velde CJ. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg. 2005;29:1576-1584. [PMID: 16317484 DOI: 10.1007/s00268-005-7907-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
24 Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin N Am 2012;21:79-97. [PMID: 22098833 DOI: 10.1016/j.soc.2011.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol. 2001;40:77-94. [PMID: 11578917 DOI: 10.1016/s1040-8428(00)00131-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
26 Batista TP, Martins MR. Lymph node dissection for gastric cancer: a critical review. Oncol Rev 2012;6:e12. [PMID: 25992202 DOI: 10.4081/oncol.2012.e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Maehara Y, Kakeji Y, Koga T, Emi Y, Baba H, Akazawa K, Sugimachi K. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery. 2002;131:S85-S91. [PMID: 11821792 DOI: 10.1067/msy.2002.119309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
28 Sauvanet A, Msika S. [Gastric antrum cancer: what intervention?]. Ann Chir 2005;130:483-6. [PMID: 16023610 DOI: 10.1016/j.anchir.2005.06.002] [Reference Citation Analysis]
29 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
30 Khushalani NI. Cancer of the Esophagus and Stomach. Mayo Clinic Proceedings 2008;83:712-22. [DOI: 10.1016/s0025-6196(11)60900-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
31 Lawson JD, Sicklick JK, Fanta PT. Gastric cancer. Curr Probl Cancer. 2011;35:97-127. [PMID: 21635986 DOI: 10.1016/j.currproblcancer.2011.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
32 Noguchi M. Is the value of regional lymph node dissection different in Breast Cancer ana Gastrointestinal Cancer? Breast Cancer 1999;6:171-4. [DOI: 10.1007/bf02967163] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
33 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2012;1:CD001964. [PMID: 22258947 DOI: 10.1002/14651858.cd001964.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
34 Latif A. Gastric cancer. Update on diagnosis, staging, and therapy. Postgrad Med 1997;102:231-6, 241. [PMID: 9336609 DOI: 10.3810/pgm.1997.10.343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
35 Hundahl SA. Eliminating and suppressing local-regional disease in gastric cancer. J Surg Oncol 2005;90:171-3. [DOI: 10.1002/jso.20224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
36 Stewart C, Chao J, Chen YJ, Lin J, Sullivan MJ, Melstrom L, Hyung WJ, Fong Y, Paz IB, Woo Y. Multimodality management of locally advanced gastric cancer-the timing and extent of surgery. Transl Gastroenterol Hepatol 2019;4:42. [PMID: 31231709 DOI: 10.21037/tgh.2019.05.02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol. 2006;93:394-400. [PMID: 16550575 DOI: 10.1002/jso.20495] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
38 Kim J. Surgical results in gastric cancer. Semin Surg Oncol 1999;17:132-8. [DOI: 10.1002/(sici)1098-2388(199909)17:2<132::aid-ssu8>3.0.co;2-e] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
39 Bösing NM, Goretzki PE, Röher HD. Gastric cancer: which patients benefit from systematic lymphadenectomy? Eur J Surg Oncol. 2000;26:498-505. [PMID: 11016473 DOI: 10.1053/ejso.1999.0930] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
40 Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease--part II. Curr Probl Surg 2005;42:796-862. [PMID: 16344044 DOI: 10.1067/j.cpsurg.2005.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Songun I, Velde CJ. Can Surgical Treatment Results in Gastric Cancer Be Improved? The Oncologist 1996;1:36-40. [DOI: 10.1634/theoncologist.1-1-36] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Valentini V, Cellini F. Radiotherapy in gastric cancer: a systematic review of literature and new perspectives. Expert Rev Anticancer Ther 2007;7:1379-93. [PMID: 17944564 DOI: 10.1586/14737140.7.10.1379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
43 Songun I, van de Velde CJ. Optimal surgery for advanced gastric cancer. Expert Rev Anticancer Ther 2009;9:1849-58. [PMID: 19954295 DOI: 10.1586/era.09.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
44 Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069-2077. [PMID: 15082726 DOI: 10.1200/jco.2004.08.026] [Cited by in Crossref: 617] [Cited by in F6Publishing: 261] [Article Influence: 34.3] [Reference Citation Analysis]
45 Kumar S, Kumar N, Deo S, Bhoriwal S, Mandal A, Sharma A, Pathy S, Das P, Thulkar S, Bhatnagar S. Patterns of Multimodality Management of Gastric Cancer—Single Institutional Experience of 372 Cases From a Tertiary Care Center in North India. Front Oncol 2022;12:877493. [DOI: 10.3389/fonc.2022.877493] [Reference Citation Analysis]
46 Gunderson LL, Tepper JE, Calvo FA, Callister MD. Gastric/GE Junction Cancer. Clinical Radiation Oncology. Elsevier; 2012. pp. 903-33. [DOI: 10.1016/b978-1-4377-1637-5.00045-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
47 Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Takeda S. Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas. 2009;38:e13-e17. [PMID: 18797422 DOI: 10.1097/mpa.0b013e3181889e2d] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
48 van de Velde CJ. Current role of surgery and multimodal treatment in localized gastric cancer. Ann Oncol 2008;19 Suppl 5:v93-8. [PMID: 18611909 DOI: 10.1093/annonc/mdn319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
49 Borie F, Plaisant N, Millat B, Hay JM, Fagniez PL. Appropriate gastric resection with lymph node dissection for early gastric cancer. Ann Surg Oncol. 2004;11:512-517. [PMID: 15078634 DOI: 10.1245/ASO.2004.06.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
50 Msika S, Kianmanesh R. Le traitement du cancer gastrique. Chirurgie 1999;124:560-7. [DOI: 10.1016/s0001-4001(00)88281-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
51 Gil-rendo A, Hernández-lizoain, Martínez-regueira F, Sierra Martínez A, Rotellar Sastre F, Delgado MC, Azcarate VV, Idoate CP, Álvarez-cienfuegos J. Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Transl Oncol 2006;8:354-61. [DOI: 10.1007/s12094-006-0182-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
52 Platell C, Cooper D, Papadimitriou JM, Hall JC. The omentum. World J Gastroenterol 2000; 6(2): 169-176 [PMID: 11819552 DOI: 10.3748/wjg.v6.i2.169] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
53 Lehnert T. Tailored lymphadenectomy for gastric cancer? Ann Surg Oncol 1998;5:563-4. [PMID: 9831098 DOI: 10.1007/BF02303819] [Reference Citation Analysis]
54 Noguchi M, Miyazaki I. Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997;65:57-65. [DOI: 10.1002/(sici)1096-9098(199705)65:1<57::aid-jso12>3.0.co;2-p] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
55 Noguchi M, Miyazakit I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 1996;83:156-61. [DOI: 10.1002/bjs.1800830205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
56 Li Z, Bai B, Xie F, Zhao Q. Distal versus total gastrectomy for middle and lower-third gastric cancer: A systematic review and meta-analysis. International Journal of Surgery 2018;53:163-70. [DOI: 10.1016/j.ijsu.2018.03.047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
57 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
58 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
59 Bremers AJ, Rutgers EJ, van de Velde CJ. Cancer surgery: the last 25 years. Cancer Treat Rev. 1999;25:333-353. [PMID: 10644500 DOI: 10.1053/ctrv.1999.0147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
60 Jansen EP, Boot H, Verheij M, van de Velde CJ. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517. [PMID: 16002841 DOI: 10.1200/JCO.2005.21.196] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
61 Mocellin S, Nitti D. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat Rev 2015;41:448-54. [PMID: 25814393 DOI: 10.1016/j.ctrv.2015.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
62 Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000;26:243-255. [PMID: 10913380 DOI: 10.1053/ctrv.2000.0164] [Cited by in Crossref: 128] [Cited by in F6Publishing: 133] [Article Influence: 5.8] [Reference Citation Analysis]
63 Macdonald JS, Hundahl S, Smalley SR, O’dea D, Mitchell EP. Gastric Cancer. In: Blanke CD, Rödel C, Talamonti MS, editors. Gastrointestinal Oncology. Berlin: Springer Berlin Heidelberg; 2011. pp. 101-38. [DOI: 10.1007/978-3-642-13306-0_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
64 Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59-100. [PMID: 12672518 DOI: 10.1016/S1040-8428(02)00160-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
65 Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol. 1999;6:46-56. [PMID: 10030415 DOI: 10.1007/s10434-999-0046-z] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 3.8] [Reference Citation Analysis]
66 Mariette C, Alves A, Benoist S, Bretagnol F, Mabrut JY, Slim K; Société Française de Chirurgie Digestive. [Perioperative care in digestive surgery]. J Chir (Paris) 2005;142:14-28. [PMID: 15883504 DOI: 10.1016/s0021-7697(05)80831-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
67 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
68 Kim JH, Kim J, Lee WJ, Seong H, Choi H, Ahn JY, Jeong SJ, Ku NS, Son T, Kim HI, Han SH, Choi JY, Yeom JS, Hyung WJ, Song YG, Noh SH. A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy. J Clin Med 2019;8:E494. [PMID: 30979055 DOI: 10.3390/jcm8040494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hundahl SA. Evidence-based recommendations for local-regional control of gastric cancer. Cancer Invest 2005;23:352-62. [PMID: 16100947 DOI: 10.1081/cnv-58885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Lawrence W Jr. Commentary: frequency of lymph node metastases to the splenic hilum. J Surg Oncol 2001;76:93-4. [PMID: 11223833 DOI: 10.1002/1096-9098(200102)76:2<93::aid-jso1017>3.0.co;2-i] [Reference Citation Analysis]
71 Qi J, Zhang P, Wang Y, Chen H, Li Y. Does Total Gastrectomy Provide Better Outcomes than Distal Subtotal Gastrectomy for Distal Gastric Cancer? A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0165179. [PMID: 27783692 DOI: 10.1371/journal.pone.0165179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
72 Mihaljevic AL, Friess H, Schuhmacher C. Clinical trials in gastric cancer and the future. J Surg Oncol 2013;107:289-97. [PMID: 22514058 DOI: 10.1002/jso.23120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
73 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355-366; discussion 366-368. [PMID: 12192322 DOI: 10.1097/01.sla.0000027272.08464.0b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
74 Schmidt-matthiesen A. Do patients really benefit from the extended lymph node dissection for gastric carcinoma Contra:. European Journal of Cancer 1998;34:1483-6. [DOI: 10.1016/s0959-8049(98)00202-0] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
75 Roukos D, Marcouizos G, Batsis C, Kappas A, Encke A. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1996;224:108-9. [PMID: 8678611 DOI: 10.1097/00000658-199607000-00022] [Reference Citation Analysis]
76 Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;30:2327-33. [PMID: 22585691 DOI: 10.1200/JCO.2011.36.7136] [Cited by in Crossref: 466] [Cited by in F6Publishing: 253] [Article Influence: 46.6] [Reference Citation Analysis]
77 Wayne JD, Bell RH. Limited Gastric Resection. Surgical Clinics of North America 2005;85:1009-20. [DOI: 10.1016/j.suc.2005.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
78 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016; 8(2): 136-146 [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
79 Watanabe M, Miyata H, Gotoh M, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Kitagawa Y, Sugihara K, Mori M. Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg. 2014;260:1034-1039. [PMID: 25072429 DOI: 10.1097/sla.0000000000000781] [Cited by in Crossref: 95] [Cited by in F6Publishing: 63] [Article Influence: 13.6] [Reference Citation Analysis]
80 Hundahl SA. Surgical quality in trials of adjuvant cancer therapy. J Surg Oncol 2002;80:177-80. [DOI: 10.1002/jso.10123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
81 Yang HK. Issues in the management of the upper third gastric cancer. Cancer Res Treat 2004;36:4-5. [PMID: 20396559 DOI: 10.4143/crt.2004.36.1.4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Lustosa SA, Saconato H, Atallah AN, Lopes Filho Gde J, Matos D. Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials. Acta Cir Bras. 2008;23:520-530. [PMID: 19030751 DOI: 10.1590/s0102-86502008000600009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
83 Bozzetti F. Principles of Surgical Radicality in the Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2001;10:833-54. [DOI: 10.1016/s1055-3207(18)30035-8] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
84 Matsukuma A, Furusawa M, Tomoda H, Seo Y. A clinicopathological study of asymptomatic gastric cancer. Br J Cancer 1996;74:1647-50. [PMID: 8932349 DOI: 10.1038/bjc.1996.603] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
85 Montgomery M, Fukuhara S, Karpeh M, Brower S. Evidence-based review of the management of early gastric cancer. Gastroenterol Rep (Oxf) 2013;1:105-12. [PMID: 24759815 DOI: 10.1093/gastro/got016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
86 Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery. Cancer Commun (Lond) 2019;39:11. [PMID: 30917873 DOI: 10.1186/s40880-019-0360-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
87 Choi YY, An JY, Cho I, Kwon IG, Kang DR, Hyung WJ, Noh SH. The assessment of the oncological safety margin of insufficient lymph node dissection in pT2 (pm) gastric cancer. Yonsei Med J. 2014;55:61-69. [PMID: 24339288 DOI: 10.3349/ymj.2014.55.1.61] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
88 Hartgrink HH, van de Velde CJ. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-65. [DOI: 10.1002/jso.20222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
89 Kurokawa Y, Yang HK, Cho H, Ryu MH, Masuzawa T, Park SR, Matsumoto S, Lee HJ, Honda H, Kwon OK, Ishikawa T, Lee KH, Nabeshima K, Kong SH, Shimokawa T, Yook JH, Doki Y, Im SA, Hirota S, Hahn S, Nishida T, Kang YK. Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach. Br J Cancer 2017;117:25-32. [PMID: 28535156 DOI: 10.1038/bjc.2017.144] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
90 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
91 Deng JY, Liang H, Sun D, Zhan HJ, Zhang RP. Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol 2008; 14(15): 2440-2447 [PMID: 18416477 DOI: 10.3748/wjg.14.2440] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
92 Cady B. Contemporary approaches to gastric carcinoma. Cancer Treat Res 1997;90:239-52. [PMID: 9367087 DOI: 10.1007/978-1-4615-6165-1_13] [Reference Citation Analysis]
93 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-66; discussion 366-8. [PMID: 12192322 DOI: 10.1097/00000658-200209000-00012] [Cited by in Crossref: 562] [Cited by in F6Publishing: 458] [Article Influence: 28.1] [Reference Citation Analysis]
94 Cozzaglio L, Doci R, Celotti S, Roncalli M, Gennari L. Gastric Cancer: Extent of Lymph Node Dissection and Requirements for a Correct Staging. Tumori 2004;90:467-72. [DOI: 10.1177/030089160409000505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
95 Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Towards Personalization in the Curative Treatment of Gastric Cancer. Front Oncol. 2020;10:614907. [PMID: 33330111 DOI: 10.3389/fonc.2020.614907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Hundahl SA, Wanebo HJ. Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol. 2005;31:605-615. [PMID: 16023944 DOI: 10.1016/j.ejso.2005.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
97 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Critical Reviews in Oncology/Hematology 2009;71:127-64. [DOI: 10.1016/j.critrevonc.2009.01.004] [Cited by in Crossref: 266] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
98 Deng J, Liang H. D2 lymphadenectomy in gastric cancer surgery. Clin Oncol Cancer Res 2009;6:162-8. [DOI: 10.1007/s11805-009-0162-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Roukos DH, Paraschou P, Lorenz M. Distal Gastric Cancer and Extensive Surgery: A New Evaluation Method Based on the Study of the Status of Residual Lymph Nodes After Limited Surgery. Ann Surg Oncol 2000;7:719-26. [DOI: 10.1007/s10434-000-0719-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
100 de Bree E, Charalampakis V, Melissas J, Tsiftsis DD. The extent of lymph node dissection for gastric cancer: a critical appraisal. J Surg Oncol. 2010;102:552-562. [PMID: 20976727 DOI: 10.1002/jso.21646] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
101 Hundahl SA. Gastric Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations. Surgical Oncology Clinics of North America 1996;5:129-44. [DOI: 10.1016/s1055-3207(18)30409-5] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
102 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
104 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
105 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
106 Sasagawa T, Solano H, Vega W, Mena F. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan. Am J Surg. 2008;195:53-60. [PMID: 18082543 DOI: 10.1016/j.amjsurg.2007.01.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
107 Zhang H, Liu C, Wu D, Meng Y, Song R, Lu P, Wang S. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer A result based on a hospital population of two decades as taking D2 surgery for reference. BMC Cancer. 2010;10:308. [PMID: 20565910 DOI: 10.1186/1471-2407-10-308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
108 Peng JJ, He YL, Zhan WH, Xiao P, Cai SR, Zhang CH, Wu H. Vagina vasorum dissection during D2 lymphadenectomy for gastric carcinoma. World J Gastroenterol 2007; 13(12): 1867-1869 [PMID: 17465483 DOI: 10.3748/wjg.v13.i12.1867] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Noshiro H, Nagai E, Shimizu S, Uchiyama A, Tanaka M. Laparoscopically assisted distal gastrectomy with standard radical lymph node dissection for gastric cancer. Surg Endosc 2005;19:1592-6. [PMID: 16247578 DOI: 10.1007/s00464-005-0175-9] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 6.4] [Reference Citation Analysis]
110 Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23:192-197. [PMID: 16837811 DOI: 10.1159/000094537] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
111 Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005;138:899-904. [PMID: 16291391 DOI: 10.1016/j.surg.2005.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
112 Lee SS, Chung HY, Kwon OK, Yu W. Long-term Quality of Life After Distal Subtotal and Total Gastrectomy: Symptom- and Behavior-oriented Consequences. Ann Surg. 2016;263:738-744. [PMID: 26501699 DOI: 10.1097/sla.0000000000001481] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
113 Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-7. [PMID: 10791852 DOI: 10.1007/BF02523656] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
114 Migita K, Takayama T, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Nakajima Y. Risk factors for surgical site infections after elective gastrectomy. J Gastrointest Surg 2012;16:1107-15. [PMID: 22350727 DOI: 10.1007/s11605-012-1838-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
115 Sue-Ling H. Radical D2 gastrectomy for cancer. The case of D2 resections. Ann R Coll Surg Engl 2007;89:672-4. [PMID: 17959003 DOI: 10.1308/003588407X209518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
116 Maehara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer. 2000;83:986-991. [PMID: 10993643 DOI: 10.1054/bjoc.2000.1427] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 3.1] [Reference Citation Analysis]
117 Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg. 2007;24:101-107. [PMID: 17446702 DOI: 10.1159/000101896] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
118 Lawrence W. Extended surgery for gastric cancer: An historical commentary. Cancer 1998;82:429-32. [DOI: 10.1002/(sici)1097-0142(19980201)82:3<429::aid-cncr1>3.0.co;2-k] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
119 Panin SI, Postolov MP, Kovalenko NV, Beburishvili AG, Fedorov AV, Bykov AV. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis]. Khirurgiia (Mosk) 2020;:93-100. [PMID: 33210514 DOI: 10.17116/hirurgia202011193] [Reference Citation Analysis]
120 Ozmen MM, Zulfikaroglu B, Kucuk NO, Ozalp N, Aras G, Koseoglu T, Koç M. Lymphoscintigraphy in detection of the regional lymph node involvement in gastric cancer. Ann R Coll Surg Engl 2006;88:632-8. [PMID: 17132310 DOI: 10.1308/003588406X149200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
121 Bando E, Kojima N, Kawamura T, Takahashi S, Fukushima N, Yonemura Y. Prognostic value of age and sex in early gastric cancer. Br J Surg. 2004;91:1197-1201. [PMID: 15449274 DOI: 10.1002/bjs.4541] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
122 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D’Ugo D. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010; 16(27): 3358-3370 [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
123 The Dutch Gastric Cancer Study Group. Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997;84:1567-71. [DOI: 10.1002/bjs.1800841121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
124 Noguchi M, Miyazaki I. Management of lymph node metastases in breast cancer and gastric cancer. J Surg Oncol 1995;60:65-71. [DOI: 10.1002/jso.2930600113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
125 Roukos DH, Kappas AM, Encke A. Extensive lymph-node dissection in gastric cancer: is it of therapeutic value? Cancer Treatment Reviews 1996;22:247-52. [DOI: 10.1016/s0305-7372(96)90018-3] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
126 Winslet MC, Mohsen YM, Powell J, Allum WH, Fielding JW. The influence of age on the surgical management of carcinoma of the stomach. Eur J Surg Oncol. 1996;22:220-224. [PMID: 8654600 DOI: 10.1016/S0748-7983(96)80006-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
127 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237-2246. [PMID: 11147594 DOI: 10.1002/1097-0142(20001201)89:11%3C2237::AID-CNCR12%3E3.0.CO;2-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Ogoshi K, Okamoto Y, Nabeshima K, Morita M, Nakamura K, Iwata K, Soeda J, Kondoh Y, Makuuchi H. Focus on the conditions of resection and reconstruction in gastric cancer. What extent of resection and what kind of reconstruction provide the best outcomes for gastric cancer patients? Digestion. 2005;71:213-224. [PMID: 16024924 DOI: 10.1159/000087046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
129 Vural V, Saylam B, Çomçalı B, Düzgün AP, Özer MV, Coşkun F. D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications. Ulus Cerrahi Derg 2013;29:1-6. [PMID: 25931833 DOI: 10.5152/UCD.2013.01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
130 Rivera F, Carrato A, Grávalos C, Pericay C, Sastre J, Aranda E. Recommendations on current approach to gastric cancer. Clin Transl Oncol 2009;11:518-25. [PMID: 19661026 DOI: 10.1007/s12094-009-0396-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
131 Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, Ustuner Z, Bavbek SE, Bugra D, Aykan FN. Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer: . American Journal of Clinical Oncology 2004;27:205-9. [DOI: 10.1097/01.coc.0000092703.12189.a2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
132 Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol. 2007;46:277-285. [PMID: 17450463 DOI: 10.1080/02841860701218634] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
133 Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K. Surgical treatment and outcome for node-negative gastric cancer. Surgery. 1997;121:633-639. [PMID: 9186463 DOI: 10.1016/S0039-6060(97)90051-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
134 Ahn HS, Kim JW, Yoo MW, Park do J, Lee HJ, Lee KU, Yang HK. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol. 2008;15:1632-1639. [PMID: 18379851 DOI: 10.1245/s10434-008-9871-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
135 Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T; Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9:278-286. [PMID: 11923135 DOI: 10.1007/bf02573066] [Cited by in Crossref: 157] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
136 Melville A, Morris E, Forman D, Eastwood A. Management of upper gastrointestinal cancers. Qual Health Care 2001;10:57-64. [PMID: 11239144 DOI: 10.1136/qhc.10.1.57] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
137 Khushalani N. Cancer of the esophagus and stomach. Mayo Clin Proc. 2008;83:712-722. [PMID: 18533089 DOI: 10.4065/83.6.712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
138 Roder JD, Bonenkamp JJ, Craven J, van de Velde CJH, Sasako M, Böttcher K, Stein HJ. Lymphadenectomy for gastric cancer in clinical trials: Update. World J Surg 1995;19:546-53. [DOI: 10.1007/bf00294718] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
139 Shimoyama S, Seto Y, Yasuda H, Mafune K, Kaminishi M. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution. World J Surg. 2005;29:58-65. [PMID: 15599744 DOI: 10.1007/s00268-004-7427-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
140 Smalley SR, Gunderson L, Tepper J, Martenson JA, Minsky B, Willett C, Rich T. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52:283-293. [PMID: 11872272 DOI: 10.1016/s0360-3016(01)02646-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
141 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2003;CD001964. [PMID: 14583942 DOI: 10.1002/14651858.cd001964.pub2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
142 Bamias A, Pavlidis N. Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today? The Oncologist 1998;3:171-7. [DOI: 10.1634/theoncologist.3-3-171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
143 Kundel Y, Levitt ML, Oberman B, Sadezki S, Tichler T, Symon Z, Catane R, Pfeffer R, Brenner B. Adjuvant Chemotherapy and Whole Abdominal Irradiation for Gastric Carcinoma. Tumori 2008;94:469-73. [DOI: 10.1177/030089160809400405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
144 Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461. [PMID: 9790335 DOI: 10.1097/00000658-199810000-00002] [Cited by in Crossref: 762] [Cited by in F6Publishing: 697] [Article Influence: 31.8] [Reference Citation Analysis]
145 Grossmann EM, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson W, Daley J, Khuri SF. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002;131:484-490. [PMID: 12019399 DOI: 10.1067/msy.2002.123806] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
146 Vadthya G, Ramakrishnaiah VPN, Krishnamachari S. Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach. Indian J Surg Oncol 2017;8:304-11. [DOI: 10.1007/s13193-017-0620-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
147 Lee SS, Chung HY, Kwon OK, Yu W. Quality of life in cancer survivors 5 years or more after total gastrectomy: a case-control study. Int J Surg. 2014;12:700-705. [PMID: 24866069 DOI: 10.1016/j.ijsu.2014.05.067] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
148 Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B, Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de Velde C. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol 2006;17 Suppl 6:vi13-8. [PMID: 16809641 DOI: 10.1093/annonc/mdl976] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
149 Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, Ohashi Y, Nakazato H. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Surg Today. 1999;29:504-510. [PMID: 10385364 DOI: 10.1007/BF02482344] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
150 Sasako M. Clinical trials of surgical treatment of malignant diseases. Int J Clin Oncol. 2005;10:165-170. [PMID: 15990963 DOI: 10.1007/s10147-005-0486-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
151 Herrera-Almario G, Strong VE. Minimally Invasive Gastric Surgery. Adv Surg 2017;51:151-64. [PMID: 28797337 DOI: 10.1016/j.yasu.2017.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
152 Skoropad V, Berdov B, Zagrebin V. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol. 2002;80:72-78. [PMID: 12173383 DOI: 10.1002/jso.10102] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
153 McCulloch P, Niita ME, Kazi H, Gama-Rodrigues JJ. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 2005;92:5-13. [PMID: 15635680 DOI: 10.1002/bjs.4839] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
154 Douridas GN, Pierrakakis SK. Is There Any Role for D3 Lymphadenectomy in Gastric Cancer? Front Surg. 2018;5:27. [PMID: 29740588 DOI: 10.3389/fsurg.2018.00027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
155 Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg. 2004;91:283-287. [PMID: 14991627 DOI: 10.1002/bjs.4433] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 6.2] [Reference Citation Analysis]
156 Zhang Y, Tian S. Does D2 plus para-aortic nodal dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades. Scand J Surg. 2013;102:251-257. [PMID: 24056132 DOI: 10.1177/1457496913491343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
157 Crookes PF, Incarbone R, Peters JH, Engle S, Bremner CG, Demeester TR. A selective therapeutic approach to gastric cancer in a large public hospital. The American Journal of Surgery 1995;170:602-5. [DOI: 10.1016/s0002-9610(99)80024-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
158 Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14 Suppl 2:ii31-ii36. [PMID: 12810455 DOI: 10.1093/annonc/mdg726] [Cited by in Crossref: 217] [Cited by in F6Publishing: 231] [Article Influence: 11.4] [Reference Citation Analysis]
159 D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808-816. [PMID: 15492562 DOI: 10.1097/01.sla.0000143245.28656.15] [Cited by in Crossref: 378] [Cited by in F6Publishing: 377] [Article Influence: 21.0] [Reference Citation Analysis]
160 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209-241. [PMID: 15890270 DOI: 10.1016/j.critrevonc.2005.01.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
161 Mineur L, Lacaine F, Ychou M, Bosset JF, Daban A. [Chemoradiotherapy in the adjuvant treatment of gastric adenocarcinomas: real progress?]. Cancer Radiother 2002;6 Suppl 1:13s-23s. [PMID: 12587378 DOI: 10.1016/s1278-3218(02)00213-5] [Reference Citation Analysis]
162 Glehen O, Traverse-Glehen A, Peyrat P, François Y, Gérard JP, Vignal J, Gilly FN. [Stomach adenocarcinoma. Evolution of surgical treatment in a series of 350 cases]. Ann Chir. 2000;125:744-751. [PMID: 11105346 DOI: 10.1016/s0003-3944(00)00268-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
163 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
164 Talamonti MS, Kim SP, Yao KA, Wayne JD, Feinglass J, Bennett CL, Rao S. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003;134:720-777; discussion 727-729. [PMID: 14605635 DOI: 10.1016/s0039-6060(03)00337-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
165 Hundahl SA. Low maruyama index surgery for gastric cancer. Scand J Surg 2006;95:243-8. [PMID: 17249272 DOI: 10.1177/145749690609500406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
166 Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal vs total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg. 1999;230:170-178. [PMID: 10450730 DOI: 10.1097/00000658-199908000-00006] [Cited by in Crossref: 268] [Cited by in F6Publishing: 209] [Article Influence: 11.7] [Reference Citation Analysis]
167 Shimoyama S, Yasuda H, Mafune K, Kaminishi M. Indications of a minimized scope of lymphadenectomy for submucosal gastric cancer. Ann Surg Oncol. 2002;9:625-631. [PMID: 12167575 DOI: 10.1007/BF02574477] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
168 Sano T, Sasako M, Katai H, Maruyama K. Amylase concentration of drainage fluid after total gastrectomy: AMYLASE IN DRAINAGE FLUID AFTER TOTAL GASTRECTOMY. Br J Surg 1997;84:1310-2. [DOI: 10.1046/j.1365-2168.1997.02764.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
169 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
170 Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253:900-911. [PMID: 21394009 DOI: 10.1097/sla.0b013e318212bff6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
171 Lardenoye JWH, Kappetein AP, Lagaay MB, Allema JH, Breslau PJ. Survival of proximal third gastric carcinoma. J Surg Oncol 1998;68:183-6. [DOI: 10.1002/(sici)1096-9098(199807)68:3<183::aid-jso10>3.0.co;2-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
172 Hundahl SA. Surgical quality control in gastric cancer trials. Surg Oncol Clin N Am 2002;11:445-58. [PMID: 12424862 DOI: 10.1016/s1055-3207(02)00014-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
173 Sano T, Sasako M, Katai H, Maruyama K. Amylase concentration of drainage fluid after total gastrectomy. Br J Surg. 1997;84:1310-1312. [PMID: 9313722 DOI: 10.1002/bjs.1800840932] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
174 Lawrence W, Horsley Iii JS. Guest editorial: “EXTENDED” lymph node dissections for gastric cancer—Is more better? J Surg Oncol 1996;61:85-9. [DOI: 10.1002/(sici)1096-9098(199602)61:2<85::aid-jso1>3.0.co;2-n] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
175 Vallbohmer D, Oh DS, Peters JH. The role of lymphadenectomy in the surgical treatment of esophageal and gastric cancer. Curr Probl Surg 2012;49:471-515. [PMID: 22793506 DOI: 10.1067/j.cpsurg.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
176 Kobayashi A, Nakagohri T, Konishi M, Inoue K, Takahashi S, Itou M, Sugitou M, Ono M, Saito N, Kinoshita T. Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg. 2004;8:464-470. [PMID: 15120372 DOI: 10.1016/j.gassur.2003.12.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
177 Carlomagno C, Matano E, Bianco R, Cimminiello C, Prudente A, Pagliarulo C, Crispo A, Cannella L, DE Stefano A, D'Armiento FP, DE Placido S. Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors. Exp Ther Med 2010;1:611-7. [PMID: 22993584 DOI: 10.3892/etm_00000096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
178 Arcangeli G, Saracino B, Arcangeli G, Angelini F, Marchetti P, Tirindelli Danesi D. Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer. International Journal of Radiation Oncology*Biology*Physics 2002;54:1069-75. [DOI: 10.1016/s0360-3016(02)03026-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
179 Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60-S69. [PMID: 22138927 DOI: 10.1007/s10120-011-0110-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
180 Disiena MR, Taneja C, Wanebo HJ. Radical Gastrectomy and Lymphadenectomy: Historic Overview, Surgical Trends, and Lessons from the Past. Surgical Oncology Clinics of North America 2005;14:511-32. [DOI: 10.1016/j.soc.2005.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
181 Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol. 2002;28:406-412. [PMID: 12099651 DOI: 10.1053/ejso.2001.1247] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
182 Hartgrink HH, Bonenkamp HJ, van de Velde CJ. Influence of Surgery on Outcomes in Gastric Cancer. Surgical Oncology Clinics of North America 2000;9:97-117. [DOI: 10.1016/s1055-3207(18)30171-6] [Cited by in Crossref: 24] [Article Influence: 1.1] [Reference Citation Analysis]
183 Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199-206. [PMID: 19142901 DOI: 10.1002/jso.21224] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
184 Mariette C, Alves A, Benoist S, Bretagnol F, Mabrut JY, Slim K. [Perioperative care in digestive surgery. Guidelines for the French society of digestive surgery (SFCD)]. Ann Chir 2005;130:108-24. [PMID: 15737324 DOI: 10.1016/j.anchir.2004.12.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
185 Clark CJ, Thirlby RC, Picozzi V, Schembre DB, Cummings FP, Lin E. Current problems in surgery: gastric cancer. Curr Probl Surg. 2006;43:566-670. [PMID: 17000267 DOI: 10.1067/j.cpsurg.2006.06.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
186 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States?: A comparison of patient survival among three institutions. Cancer 2000;89:2237-46. [DOI: 10.1002/1097-0142(20001201)89:11<2237::aid-cncr12>3.0.co;2-9] [Cited by in Crossref: 120] [Article Influence: 5.5] [Reference Citation Analysis]
187 Guadagni S, Catarci M, de Manzoni G, Kinoshita T. D1 versus D2 dissection for gastric cancer. Lancet 1995;345:1517; author reply 1517-8. [PMID: 7769935 [PMID: 7769935 DOI: 10.1016/s0140-6736(95)91078-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
188 Skoropad VY, Berdov BA, Mardynski YS, Titova LN. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000;26:773-779. [PMID: 11087644 DOI: 10.1053/ejso.2000.1002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
189 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
190 Liu Z, Feng F, Guo M, Liu S, Zheng G, Xu G, Lian X, Fan D, Zhang H. Distal gastrectomy versus total gastrectomy for distal gastric cancer. Medicine (Baltimore). 2017;96:e6003. [PMID: 28151896 DOI: 10.1097/md.0000000000006003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
191 Orditura M, Martinelli E, Galizia G, Vitiello F, Fasano M, Muto P, Ciardiello F, De Vita F. Chemoradiotherapy as adjuvant treatment of gastric cancer. Ann Oncol 2007;18 Suppl 6:vi133-5. [PMID: 17591807 DOI: 10.1093/annonc/mdm242] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
192 Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, Aapro M. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer. 2008;44:182-194. [PMID: 18093827 DOI: 10.1016/j.ejca.2007.11.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
193 Macdonald JS. Advances in the therapy of gastric cancer. Gastric Cancer 2002;5 Suppl 1:35-40. [PMID: 12772886 DOI: 10.1007/s10120-002-0205-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
194 Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates: High Survival Rates for Asians with Gastric Carcinoma. Cancer 2000;89:1883-92. [DOI: 10.1002/1097-0142(20001101)89:9<1883::aid-cncr3>3.0.co;2-h] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
195 Spanknebel KA, Brennan MF. Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Surg Oncol Clin N Am. 2002;11:415-30, xii. [PMID: 12424860 DOI: 10.1016/s1055-3207(02)00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
196 Boda-Heggemann J, Hofheinz RD, Weiss C, Mennemeyer P, Mai SK, Hermes P, Wertz H, Post S, Massner B, Hieber U, Hochhaus A, Wenz F, Lohr F. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer. Int J Radiat Oncol Biol Phys. 2009;75:1187-1195. [PMID: 19409725 DOI: 10.1016/j.ijrobp.2008.12.036] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
197 Leong T, Michael M, Foo K, Thompson A, Lim Joon D, Weih L, Ngan S, Thomas R, Zalcberg J. Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation. Br J Cancer. 2003;89:1433-1438. [PMID: 14562013 DOI: 10.1038/sj.bjc.6601311] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
198 Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, van Sandick JW. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol 2013;20:381-98. [PMID: 23054104 DOI: 10.1245/s10434-012-2574-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
199 Seo KW, Yoon KY, Lee SH, Shin YM, Choi KH, Hwang HY. Amylase, lipase, and volume of drainage fluid in gastrectomy for the early detection of complications caused by pancreatic leakage. J Korean Surg Soc. 2011;81:402-407. [PMID: 22200041 DOI: 10.4174/jkss.2011.81.6.402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
200 Peeters K, van de Velde C. Quality assurance of surgery in gastric and rectal cancer. Critical Reviews in Oncology/Hematology 2004;51:105-19. [DOI: 10.1016/j.critrevonc.2004.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
201 Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol. 2005;31:595-604. [PMID: 15919174 DOI: 10.1016/j.ejso.2005.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
202 Meszoely IM, Chapman WC, Holzman MD, Leach SD. New trends in gastrointestinal surgical oncology. Cancer Treat Res 1998;98:239-91. [PMID: 10326672 DOI: 10.1007/978-1-4615-4977-2_10] [Reference Citation Analysis]
203 Kim JP. Current status of surgical treatment of gastric cancer. J Surg Oncol. 2002;79:79-80. [PMID: 11815992 DOI: 10.1002/jso.10050] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
204 Noguchi M, Miyazakit I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer: LYMPH NODE METASTASIS IN GASTRIC CANCER. Br J Surg 1996;83:156-61. [DOI: 10.1046/j.1365-2168.1996.02183.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Papadimitriou K, Antoniou G, Rolfo C, Russo A, Bronte G, Vassiliou V, Papamichael D, Peeters M, Kountourakis P. Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward. Gastroenterol Res Pract 2015;2015:650846. [PMID: 26101524 DOI: 10.1155/2015/650846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
206 Meyer H, J�hne J. Lymph node dissection for gastric cancer. Semin Surg Oncol 1999;17:117-24. [DOI: 10.1002/(sici)1098-2388(199909)17:2<117::aid-ssu6>3.0.co;2-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
207 Natarajan S, Taneja C, Cady B. Evolution of Lymphadenectomy in Surgical Oncology. Surgical Oncology Clinics of North America 2005;14:447-59. [DOI: 10.1016/j.soc.2005.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
208 Lee WJ, Wang W, Chen TC, Chen JC, Ser KH. Totally laparoscopic radical BII gastrectomy for the treatment of gastric cancer: a comparison with open surgery. Surg Laparosc Endosc Percutan Tech. 2008;18:369-374. [PMID: 18716536 DOI: 10.1097/sle.0b013e31816fdd44] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
209 Marcenaro M, Foppiano F, Durzu S, Barra S, Corvò R. Kidney-Sparing Radiotherapy by Multiple-Field Three-Dimensional Technique in the Postoperative Management of Patients with Gastric Cancer: Comparison with Standard Two-Field Conformal Technique. Tumori 2006;92:34-40. [DOI: 10.1177/030089160609200107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
210 Russell MC, Mansfield PF. Surgical approaches to gastric cancer. J Surg Oncol. 2013;107:250-258. [PMID: 22674546 DOI: 10.1002/jso.23180] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
211 Theuer CP, Al-kuran R, Akiyama Y, Okumura M, Ziogas A, Carpenter PM. Increased Epithelial Cadherin Expression among Japanese Intestinal-Type Gastric Cancers Compared with Specimens from American Patients of European Descent. The American Surgeon 2006;72:332-8. [DOI: 10.1177/000313480607200412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
212 Jiang L, Yang K, Chen Y, Guan Q, Zhao P, Tian J, Wang Q. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. British Journal of Surgery 2014;101:595-604. [DOI: 10.1002/bjs.9497] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
213 Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Total gastrectomy with “over-D1” lymph node dissection: what is the actual impact of age? The American Journal of Surgery 2012;204:732-40. [DOI: 10.1016/j.amjsurg.2012.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
214 Roukos D, Schmidt-Mathiesen A, Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surg Oncol 1995;4:323-32. [PMID: 8809955 DOI: 10.1016/s0960-7404(10)80045-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
215 Beamish AJ, Chan DS, Blake PA, Karran A, Lewis WG. Systematic review and meta-analysis of enhanced recovery programmes in gastric cancer surgery. Int J Surg. 2015;19:46-54. [PMID: 26004350 DOI: 10.1016/j.ijsu.2015.05.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
216 Hu Y, Zaydfudim VM. Quality of Life After Curative Resection for Gastric Cancer: Survey Metrics and Implications of Surgical Technique. J Surg Res 2020;251:168-79. [PMID: 32151826 DOI: 10.1016/j.jss.2020.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
217 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
218 Bonenkamp JJ, van de Velde CJ. Lymph node dissection in gastric cancer. Br J Surg. 1995;82:867-869. [PMID: 7648094 DOI: 10.1002/bjs.1800820703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
219 Kodera Y, Schwarz RE, Nakao A. Extended lymph node dissection in gastric carcinoma. Journal of the American College of Surgeons 2002;195:855-64. [DOI: 10.1016/s1072-7515(02)01496-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]